Whole Genome Sequence Data From Captive Baboons Implicate RBFOX1 in Epileptic Seizure Risk by Kos, Mark Z et al.
University of Texas Rio Grande Valley 
ScholarWorks @ UTRGV 
School of Medicine Publications and 
Presentations School of Medicine 
8-20-2021 
Whole Genome Sequence Data From Captive Baboons Implicate 
RBFOX1 in Epileptic Seizure Risk 
Mark Z. Kos 
The University of Texas Rio Grande Valley, mark.kos@utrgv.edu 
Melanie A. Carless 
The University of Texas at San Antonio 
Lucy Blondell 
The University of Texas Rio Grande Valley 
M. Michelle Leland 
Koyle D. Knape 
UT Health San Antonio 
See next page for additional authors 
Follow this and additional works at: https://scholarworks.utrgv.edu/som_pub 
 Part of the Genetic Structures Commons 
Recommended Citation 
Kos, M. Z., Carless, M. A., Blondell, L., Leland, M. M., Knape, K. D., Göring, H., & Szabó, C. Á. (2021). Whole 
Genome Sequence Data From Captive Baboons Implicate RBFOX1 in Epileptic Seizure Risk. Frontiers in 
genetics, 12, 714282. https://doi.org/10.3389/fgene.2021.714282 
This Article is brought to you for free and open access by the School of Medicine at ScholarWorks @ UTRGV. It has 
been accepted for inclusion in School of Medicine Publications and Presentations by an authorized administrator 
of ScholarWorks @ UTRGV. For more information, please contact justin.white@utrgv.edu, 
william.flores01@utrgv.edu. 
Authors 
Mark Z. Kos, Melanie A. Carless, Lucy Blondell, M. Michelle Leland, Koyle D. Knape, Harald HH Goring, and 
Charles A. Szabo 
This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/som_pub/416 
fgene-12-714282 August 16, 2021 Time: 13:52 # 1
ORIGINAL RESEARCH
published: 20 August 2021
doi: 10.3389/fgene.2021.714282
Edited by:
Lawrence Todd Reiter,
University of Tennessee Health
Science Center (UTHSC),
United States
Reviewed by:
James S. Sutcliffe,
Vanderbilt University, United States
Olivia J. Veatch,
University of Kansas Medical Center,
United States
*Correspondence:
Mark Z. Kos
mark.kos@utrgv.edu
†ORCID:
Mark Z. Kos
orcid.org/0000-0003-3129-7057
Melanie A. Carless
orcid.org/0000-0001-8350-2302
Harald H. H. Göring
orcid.org/0000-0002-0507-088X
Charles Ákos Szabó
orcid.org/0000-0003-2058-3357
Specialty section:
This article was submitted to
Genetics of Common and Rare
Diseases,
a section of the journal
Frontiers in Genetics
Received: 25 May 2021
Accepted: 27 July 2021
Published: 20 August 2021
Citation:
Kos MZ, Carless MA, Blondell L,
Leland MM, Knape KD, Göring HHH
and Szabó CÁ (2021) Whole Genome
Sequence Data From Captive
Baboons Implicate RBFOX1
in Epileptic Seizure Risk.
Front. Genet. 12:714282.
doi: 10.3389/fgene.2021.714282
Whole Genome Sequence Data From
Captive Baboons Implicate RBFOX1
in Epileptic Seizure Risk
Mark Z. Kos1*†, Melanie A. Carless2,3†, Lucy Blondell1, M. Michelle Leland4,
Koyle D. Knape5, Harald H. H. Göring1† and Charles Ákos Szabó5,6†
1 Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School
of Medicine, Edinburg, TX, United States, 2 Department of Biology, The University of Texas at San Antonio, San Antonio, TX,
United States, 3 Brain Health Consortium, The University of Texas at San Antonio, San Antonio, TX, United States,
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In this study, we investigate the genetic determinants that underlie epilepsy in a captive
baboon pedigree and evaluate the potential suitability of this non-human primate model
for understanding the genetic etiology of human epilepsy. Archived whole-genome
sequence data were analyzed using both a candidate gene approach that targeted
variants in baboon homologs of 19 genes (n = 20,881 SNPs) previously implicated
in genetic generalized epilepsy (GGE) and a more agnostic approach that examined
protein-altering mutations genome-wide as assessed by snpEff (n = 36,169). Measured
genotype association tests for baboon cases of epileptic seizure were performed
using SOLAR, as well as gene set enrichment analyses (GSEA) and protein–protein
interaction (PPI) network construction of top association hits genome-wide (p < 0.01;
n = 441 genes). The maximum likelihood estimate of heritability for epileptic seizure
in the pedigreed baboon sample is 0.76 (SE = 0.77; p = 0.07). Among candidate
genes for GGE, a significant association was detected for an intronic SNP in RBFOX1
(p = 5.92 × 10−6; adjusted p = 0.016). For protein-altering variants, no genome-
wide significant results were observed for epilepsy status. However, GSEA revealed
significant positive enrichment for genes involved in the extracellular matrix structure
(ECM; FDR = 0.0072) and collagen formation (FDR = 0.017), which was reflected
in a major PPI network cluster. This preliminary study highlights the potential role of
RBFOX1 in the epileptic baboon, a protein involved in transcriptomic regulation of
multiple epilepsy candidate genes in humans and itself previously implicated in human
epilepsy, both focal and generalized. Moreover, protein-damaging variants from across
the genome exhibit a pattern of association that links collagen-containing ECM to
epilepsy risk. These findings suggest a shared genetic etiology between baboon and
human forms of GGE and lay the foundation for follow-up research.
Keywords: whole-genome sequence, association test, Papio, baboon, idiopathic generalized epilepsy, epilepsy,
genetic generalized epilepsy, RBFOX1
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INTRODUCTION
Epilepsy is a chronic, highly heterogeneous neurological disorder,
with recurrent seizures being the diagnostic hallmark. Genetic
generalized epilepsies (GGEs) account for at least 40% of
United States cases, (Durón et al., 2005) with heritability
estimates from twin studies ranging from 25 to 69% (Kjeldsen
et al., 2001). With the rise of high-throughput genomic
sequencing, a multitude of epilepsy-associated genetic variants
have been identified in recent years, including rare variants,
such as recurrent microdeletions of large effect (Epi 4K
Consortium and Epilepsy Phenome/Genome Project, 2017).
Currently, epilepsies are suspected of having complex polygenic
architectures, involving variants of many genes from across
the frequency spectrum. However, segregation analyses in some
families have shown that rare pathogenic variants convey most
of the risk, (Myers and Mefford, 2016) with a potentially
important role played by de novo mutagenesis, as established in
patients with focal and generalized epilepsies as well as epileptic
encephalopathies (Jones et al., 2011).
Toward elucidating the various genes and molecular
mechanisms underlying epileptogenesis and seizure generation,
animal models have played a critical role, as clinical studies
of human patients preclude the possibility of invasive, and
often more insightful, methods. For decades now, rodents
have been the most common animal models used in epilepsy
research, contributing greatly toward our understanding of
acquired epilepsy and acutely induced seizure events. For
chronic phenotypes that more closely resemble human epilepsy,
a number of well-described mouse models have been developed
that exhibit spontaneous absence-like seizures with spike-
wave EEG discharges analogous to GGE, but with important
drawbacks, most notably their monogenic basis and other
neurological abnormalities. More promising are two rat models
with presumed polygenic inheritance, Genetic Absence Rats
from Strasbourg (GAERS) and Wistar Albino Glaxo rat from
Rijswijk (WAG/Rij), (Gauguier et al., 2004; Rudolf et al.,
2004) that have shown electroclinical and pathophysiological
similarities to human GGE with absence epilepsy. Despite
these successes, translatability of these models is limited due to
differences in neurodevelopment and the natural evolutionary
histories of the species, as well as response to treatment, (Löscher,
2017) suggesting the need for alternate animal models that can
further characterize the complex genetic architecture of GGE in
humans and better identify new etiological pathways with novel
therapeutic targets.
Baboons are suitable genetic models for humans, as their
genomes are more similar to humans than those of less
closely related model organisms, and share neuroanatomical,
biochemical, and physiological features stemming from their
close phylogenetic relationship. Baboons have been used as
animal models in a broad range of human diseases, including
diabetes, heart disease, osteoporosis, and chronic infectious
diseases (Rogers and Hixson, 1997). Baboons also represent a
natural model for GGE (Szabó et al., 2012, 2013; Croll et al.,
2019). For the pedigreed baboon colony housed at the Southwest
National Primate Research Center (SNPRC; San Antonio, TX,
United States), absence, myoclonic, and generalized tonic–
clonic seizures have been reported to occur spontaneously or
triggered by intermittent light stimulation, with electroclinical
findings suggesting strong similarities with human epilepsy, in
particular juvenile myoclonic epilepsy (Szabó et al., 2013). In
a preliminary analysis of 1,400 animals, (Croll et al., 2019)
we previously estimated moderate heritabilities for seizures
(h2 = 0.33, p < 1 × 10−7) and interictal epileptic discharges
(h2 = 0.19, p < 0.002), although the underlying genetic variants
are unknown. With high-throughput whole-genome sequencing
(WGS) now performed on a subset of these animals and
the potential enrichment of rare pathogenic variants within
large multigenerational pedigrees that improve statistical power
for detecting their risk effects, the SNPRC baboon colony
represents a largely untapped genetic resource for epilepsy
research (Jun et al., 2018).
This study provides an initial assessment of the baboon as a
genetic model for epilepsy. Archived WGS data from the SNPRC
colony were tested for genetic associations with epileptic seizure,
targeting single nucleotide polymorphisms (SNPs) within GGE-
associated genes, as well as protein-altering variants genome-
wide. Based on these results, as well as pathway enrichment
analyses of top association hits, a significant association was
observed for a common variant in the gene RBFOX1 (RNA
Binding Fox-1 Homolog 1), providing insight into the etiological
underpinnings of the disorder.
MATERIALS AND METHODS
Baboon Colony
There are currently about 1,000 baboons in the pedigreed
colony housed at the SNPRC, representing a mixture of species,
with extensive veterinary records generated since 1980. The
animals have been treated in strict accordance with United States
Public Health Service policy, (Institute for Laboratory Animal
Research, 1996) with regular inspections by the United States
Department of Agriculture (latest inspection in 2019). This
study was approved by the IACUC of the University of Texas
Health Science Center at San Antonio and the Texas Biomedical
Research Institute.
We performed a retrospective survey of seizures from
veterinary records available for 1,528 baboons, both living
and deceased. This included both witnessed seizures, either
spontaneous or provoked by ketamine administration or
handling, and suspected seizures, assessed by treatments for
head injuries, in particular craniofacial trauma that are often
related to falls during seizures, as well as peri-ictal behaviors
such as confusion and lethargy. As previously reported, (Szabó
et al., 2012) a total of 3,389 seizure events were detected in the
records of 1,098 baboons, of which 1,537 (45%) were witnessed
in 404 animals, with 1,267 (82%) being unprovoked. For this
study, archived WGS data were available for 90 baboons with
clinical histories [Papio hamadryas anubis (P.h. anubis) and P.h.
anubis/cynocephalus hybrids], including scalp EEG recordings of
interictal epileptic discharges for 53 of these animals (Szabó et al.,
2013). Diagnosis of epilepsy was adapted from criteria established
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by the International League Against Epilepsy (ILAE), (Fisher
et al., 2014) including: (1) evidence of at least one witnessed
seizure or craniofacial trauma with a diagnostic EEG; (2) two
or more witnessed seizures or craniofacial trauma without a
diagnostic EEG; (3) or recording of seizures, spontaneous or
photoepileptic, by video-EEG (Szabó et al., 2013, 2014). Baboons
without a history of witnessed seizures and/or craniofacial
trauma and normal EEG measures constituted our control
group. Using these criteria, 42 baboons were diagnosed with
epilepsy, 19 as healthy controls, and 29 as indeterminate (single
witnessed seizure or acute craniofacial trauma and without a
diagnostic EEG).
Processing of Archived WGS Data
Archived WGS data for the SNPRC baboon colony are available
in the NCBI Sequence Read Archive (SRA) repository. These
data have been submitted under BioProject PRJNA433868,
described as a “mixture of low-coverage and high-coverage
whole-genome sequence data” generated on Illumina HiSeq X
Ten and HiSeq 2500 instruments. Using a submission date
cut-off of 8/2/2018, a total of 791 WGS runs representing
788 different baboons were downloaded as compressed SRA-
formatted files onto the STDOI Genomics Computing Center
cluster at the University of Texas Rio Grande Valley using the
SRA FTP platform (command prefetch, followed by fastq-dump),
representing approximately 11 TB of data.
For the 90 baboons that were assessed for epileptic seizure,
FASTQ files were extracted from the compressed WGS files,
representing about 6.8 × genomic coverage on average, and
then aligned against the reference P.h. anubis genome assembly
“Panu_3.0” (NCBI BioProject PRJNA54005) with the software
BWA v. 0.7.12, (Li and Durbin, 2010) using the faster and
more accurate BWA-MEM algorithm (Li, 2013) and compressed
into the binary BAM format using the SamFormatConverter
Java executable in the software package Picard v. 1.1211
Using the Picard toolkit, the aligned sequences were then
(1) soft-clipped for beyond-end-of-reference alignments with
CleanSam; (2) sorted based on genomic coordinates with
AddOrReplaceReadGroups, with meta information added to the
reads; (3) tagged for duplicate reads with MarkDuplicates; (4)
confirmed for their consistency to the SAM format specifications
with ValidateSamFile; and (5) used to generate BAM index
files with BuildBamIndex to allow for faster processing of the
data downstream.
For the next steps in the WGS pipeline, the GATK genomic
analysis toolkit (v. 3.5 and v. 4.1.3.0) (McKenna et al., 2010)
was employed as follows: (1) potential mapping errors due
to indel events were identified in the tagged BAM files and
realigned with RealignerTargetCreator and IndelRealigner; (2)
quality scores for individual base calls were examined and
adjusted for systematic technical errors stemming from the
original sequencing work using base quality score recalibration
(BQSR), a machine-learning approach to empirically build a
covariation model of these errors using a set of known variants [in
this case, previously published sequence variation of six species
1http://broadinstitute.github.io/picard
of Papio baboon and Theropithecus gelada (Rogers et al., 2019)];
(3) call SNPs from realigned and recalibrated sequence data via
local de novo assembly using HaplotypeCaller (using -ERC GVCF
mode); (4) aggregate the resulting 90 GVCF files into multi-
sample “datastores” per chromosome using GenomicsDBImport;
and (5) perform joint genotyping on each datastore with
GenotypeGVCFs, creating raw SNP VCF files.
Lastly, based on recommendations made by the GATK
development team,2 low-quality SNPs were excluded from the
genotyped VCF files using SelectVariants for the following hard
thresholds: Phred-scaled quality score (QUAL) < 30; quality
score by depth (QD) < 2; symmetric odds ratio (SOR) > 3;
measure of strand bias by Fisher’s exact test (FS) > 60;
root mean square of mapping quality (MQ) < 40; rank sum
test for mapping qualities of reference and alternate allele
reads (MQRankSum) < −12.5; rank sum test for relative
positioning of reference and alternate alleles within reads
(ReadPosRankSum) <−8; and allele frequency (AF) < 0.05.
Genetic Analyses
The WGS data were examined using both candidate gene and
genome-wide approaches to improve the statistical power of
the study. For the former, genes implicated in GGE or the
synonymous idiopathic generalized epilepsy (IGE) were reviewed
as positional candidate genes by searching the PubMed database
with the following terms:
(GENE NAME) AND [(“genetic generalized epilepsy”) OR
(“idiopathic generalized epilepsy”) OR (“childhood absence
epilepsy”) OR (“juvenile absence epilepsy”) OR (“juvenile
myoclonic epilepsy”)].
The search was not exhaustive but limited to genes with
a priori evidence for GGE susceptibility in the databases Online
Mendelian Inheritance in Man (OMIM) and EpilepsyGene, (Ran
et al., 2015) including genetic epilepsy with febrile seizures
plus, childhood absence epilepsy, juvenile absence epilepsy, and
juvenile myoclonic epilepsy. Positional candidate genes were
identified as such by evaluating the collective in silico evidence
yielded by the PubMed search, including the seminal GWAS
mega-analysis conducted by ILAE, (The International League
Against Epilepsy Consortium on Complex Epilepsies, 2018)
with particular emphasis paid to studies that independently
reported significant associations or familial segregation of
gene variants and any of the various forms of GGE (thus
disqualifying novel, unreplicated findings). In the end, 19
positional candidate genes for GGE were selected for our study,
with each having a homologous gene or homolog in the baboon
genome (confirmed using the chain/net alignments for genomes
GRCh38 and Panu_3.0 from the UCSC Genome Browser): BRD2,
CACNA1A, CACNA1H, CACNB4, CASR, CHRNA7, EFHC1,
GABRA1, GABRA6, GABRB3, GABRD, GABRG2, ICK, ME2,
NIPA2, PNPO, RBFOX1, SCN1A, and SLC2A1.
Heritability (h2) estimation and genetic association testing
were performed using the software SOLAR, (Almasy and
Blangero, 1998) based on maximum likelihood variance
2https://gatk.broadinstitute.org/hc/en-us/articles/360035531112--How-to-Filter-
variants-either-with-VQSR-or-by-hard-filtering
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decomposition. Genetic relationships between the baboons
were inferred from a previously reported, single six-generation
pedigree comprising 2,455 animals, including 38 cases of
epileptic seizure and 16 controls with processed WGS data (total
n = 54), which were the focus of the genetic analyses. Associations
between SNPs and seizure status were computed using measured
genotype association (MGA) analysis under a liability threshold
in which kinship is treated as a random effect and SNPs as
fixed effects, with sex and the first principal component (PC) as
covariates. The likelihoods of the MGA models, each maximized
for the effects of kinship and SNP genotypes, were compared
to null models with SNP effects constrained to zero. For the
baboon homologs of the 19 positional candidate genes for GGE,
20,881 SNPs were identified in the WGS data (including variants
5 kb upstream and downstream of the leading and trailing
UTR sequences) and tested for association. A more agnostic,
genome-wide approach was also taken, in which protein-altering
variants of “moderate” impact (e.g., missense variants) and
“high” impact (e.g., start and stop codons gained or lost, splice
acceptor and donor site mutations) on protein function were
tested in a separate run (n = 36,169 SNPs). These variants were
predicted by the annotation tool SnpEff (Cingolani et al., 2012b)
using a SNP prediction library built for assembly Panu_3.0/Panu
4 (gene annotation GTF files downloaded from the UCSC
database) and filtered with SnpSift (Cingolani et al., 2012a).
Association p-values were adjusted for the effective number of
independent SNPs tested, which was estimated per chromosome
in SOLAR using the Li & Ji method (Li and Ji, 2005) based on the
computation of eigenvalues of a genotypic correlation matrix.
For the association results of genome-wide deleterious SNPs,
the genes impacted by these variants (and with known human
homologs) were tested for enrichment for genes from biological
pathways and molecular ontologies using the program Gene
Set Enrichment Analysis (GSEA v. 4.1) (Subramanian et al.,
2005) for the Molecular Signatures Database (MSigDB v. 7.2).
GSEA represents a modified Kolmogorov–Smirnov test, with
significance of the unweighted enrichment score established via
10,000 permutations. Additionally, protein–protein interaction
(PPI) networks were constructed for these results using the
online tool STRING v. 11.0, (Szklarczyk et al., 2019) limited to
interactions of “high confidence” (score ≥ 0.7) from all available
sources, with functional enrichment analysis performed on PPI
nodes for the entire network, as well as targeted analysis of the
largest observed cluster, for reactome pathways and GO-terms.
Assessment of Inflation of the
Association Test Statistic
Potential inflation of the MGA test statistic was assessed by
calculating the genomic inflation factor λ (ratio of the median
of the empirically observed distribution of χ2 to the expected
median of 0.456). This was done for 10 random subsets of 20,881
intragenic SNPs from the processed WGS data (mirroring the
number of SNPs tested in the 19 candidate genes). For the
MGA model with sex as the sole covariate, some inflation was
observed among association results generated for these random
subsets, with a mean λ of 1.13 (SD = 0.02), suggesting potential
confounding due to population substructure. To investigate
this, principal components analysis (PCA) was performed on
WGS data from autosomes 1–20 (n = 5,542,179 SNPs) with the
EIGENSTRAT method, using the statistical package AssocTests v.
1.0-1 (Wang et al., 2020) in R v. 4.0.3. (R Core Team, 2020). A plot
of the first two PCs (accounting for 9.0 and 4.6% of the genotypic
variation, respectively; see Supplementary Figure 1) revealed
stratification within the baboon sample, especially relative to the
first PC. Hence, PC1 was included as a covariate in the MGA
model and association testing was re-run on the random SNP
subsets, effectively controlling the genome-wide inflation, with
a mean λ of 1.01 (SD = 0.01). Thus, sex and PC1 were used as
covariates in all MGA tests performed in the study.
RESULTS
SNP Association Testing of GGE
Candidate Gene Homologs
After realignment and recalibration of the base quality scores
of the baboon WGS data, a total of 46,947,610 variants, both
SNPs and indels, were successfully called. These variants were
then filtered for various QC thresholds, targeting SNPs within
known genic regions, yielding 5,634,214 SNPs for 54 case-control
animals. For this subset, variant confidence scores normalized
by sequence coverage (QualByDepth or QD) range from 2.0
to 42.9, with a mean of 17.5 and median of 16.0 (SD = 6.0).
Most (∼79%) of the variants are intronic, with a transition-to-
transversion (Ts/Tv) ratio of 2.48. Over 25 million effects on
gene products were identified with SnpEff, with 110,771 (0.4%)
and 2,394 (0.009%) characterized as “MODERATE” and “HIGH,”
respectively, including ones arising from missense and nonsense
mutations and splice site variants.
Using a maximum likelihood, variance components approach
to our genetic analyses, heritability of epileptic seizure in the
baboon cohort was estimated at 0.77 (SE = 0.73; p = 0.07).
Targeting baboon homologs of genes implicated in GGE and
related epilepsies in humans, 20,881 QC filtered SNPs from
19 genes were tested for association with epileptic seizure
(see Table 1 and Supplementary Table 1; λ = 1.10). The
effective number of independent SNPs tested for association
(i.e., accounting for LD between variants) was estimated at
2,686 using the Li & Ji method, (Li and Ji, 2005) which
was used in the adjustment of p-values for multiple testing
via the conservative Bonferroni method. The top association
result is for a common intronic SNP in the gene RBFOX1
[chromosome 20 (NC_018171), base pair (bp) position 5,642,021
in intron 3 (ENSPANT00000033712.2); minor allele frequency
(MAF) = 0.48], with an estimated β coefficient of 1.37 (SE = 0.30)
and Bonferroni-corrected p = 0.016 (raw p = 5.92 × 10−6; see
Figure 1). The SNP was successfully genotyped for 51 of the 54
animals, with genotype ratios (AA:AG:GG) of 0:3:12 for healthy
controls and 17:12:7 for cases of epileptic seizure, revealing a
significant enrichment of the A allele among cases (29 carriers;
AF = 0.64) relative to controls (three carriers, all heterozygotes;
AF = 0.1). The QC sequencing metrics for the called SNP appear
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TABLE 1 | Top ten candidate genes based on SNP association results for epileptic seizure in baboons.
Epilepsy seizure
Gene Chr Position (bp) MA MAF Variant type Beta (SE) p-Value
RBFOX1 20 5,642,021 A 0.48 Intron 1.37 (0.30) 5.92 × 10−6*
GABRB3 7 2,517,399 G 0.10 Intron 5.64 (1.58) 3.67 × 10−4
SCN1A 12 51,750,877 A 0.22 Intron 3.94 (1.24) 1.50 × 10−3
GABRG2 6 156,497,930 C 0.09 Intron 1.42 (0.45) 1.73 × 10−3
CASR 2 41,913,861 A 0.08 Intron 4.65 (1.52) 2.29 × 10−3
CACNA1A 19 12,102,543 T 0.19 Synonymous 3.56 (1.19) 2.84 × 10−3
GABRA1 6 156,221,558 C 0.15 Intron 3.54 (1.25) 3.42 × 10−3
CHRNA7 7 6,949,236 C 0.09 Intron 5.19 (1.77) 3.43 × 10−3
BRD2 4 32,316,440 G 0.03 Upstream 4.38 (1.50) 3.49 × 10−3
ICK 4 52,249,073 A 0.09 Intron 4.78 (1.68) 4.55 × 10−3
The table lists the top ten gene homologs for human candidate genes for GGE and related epilepsies based on their top SNP association results for epileptic
seizure in baboons.
SNP positions relative to reference P.h. anubis genome assembly Panu_3.0 (NCBI BioProject PRJNA54005).
Variant type determined with the annotation tool SnpEff.
*Significant after Bonferroni correction for multiple testing (α = 0.05/2,686 = 1.86 × 10−5).
FIGURE 1 | Manhattan plot for part of RBFOX1 (chromosome 20: 5.34–6.20 Mb), covering exons 2, 3, 4 and 5, and introns 2, 3, and 4. The top SNP association
result is shown as a red diamond.
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TABLE 2 | Top ten genome-wide association results for protein-altering SNPs.
Epilepsy seizure
Gene Chr Position (bp) MA MAF Variant type Beta (SE) p-Value
SYNE1 4 110,510,700 C 0.06 Missense 4.35 (0.97) 7.52 × 10−6
PBXIP1 1 125,308,470 G 0.32 Missense 4.09 (0.96) 2.02 × 10−5
SYCP1 1 112,209,853 A 0.18 Missense 5.63 (1.33) 2.21 × 10−5
LOC108584956 3 43,438,092 A 0.06 Missense 5.93 (1.42) 3.02 × 10−5
MLLT6 16 45,549,650 G 0.20 Missense 5.61 (1.38) 4.51 × 10−5
ZNF692 1 217,379,527 G 0.24 Missense 5.44 (1.33) 4.61 × 10−5
GLYAT 14 14,601,373 G 0.42 Missense 1.37 (0.34) 5.16 × 10−5
RRM2B 8 97,957,365 T 0.44 Missense 1.15 (0.30) 1.04 × 10−4
UHRF1BP1 4 34,215,535 A 0.07 Missense 5.31 (1.39) 1.31 × 10−4
SELENOP 6 42,584,897 C 0.19 Missense 5.02 (1.34) 1.82 × 10−4
The table lists the top ten SNP association results for epilepsy seizure in baboons for genome-wide variants with deleterious effects on gene products (n = 36,169), as
predicted by SnpEff (variants deemed as having either “moderate” or “high” deleterious effect).
SNP positions relative to reference P.h. anubis genome assembly Panu_3.0 (NCBI BioProject PRJNA54005).
Mutation types analyzed included missense, nonsense, stop codon lost, start codon lost, splice acceptor, and splice donor variants.
satisfactory, including: QD = 31.3; average genotype quality score
(GQ) = 32.3; and approximately 5.9× depth of coverage.
Genome-Wide Association Testing of
Protein-Altering Variants
Given the limited sample size, any comprehensive examination
of the millions of called SNPs would be severely underpowered.
To achieve a genome-wide perspective of the WGS data, protein-
altering SNPs with predicted deleterious effects (n = 36,169) were
selected for a second round of association testing. It is likely
that many of the genetic determinants that underlie seizures
in baboons impact protein structure, and thus, targeting this
mutation class may allow for broader, functionally meaningful
association patterns to emerge. The top association (see Table 2
and Supplementary Table 2; λ = 1.07) is for a missense variant
(p.Glu2066Gln) in the gene SYNE1 (β = 4.35, SE = 0.97;
p = 7.52 × 10−6), which is statistically non-significant after
multiple-testing correction. Although the gene has no reported
links to epilepsy, SYNE1 has been identified as the causal gene
underlying spinocerebellar ataxia 1 (Gros-Louis et al., 2007).
For SNP associations with p-values less than 0.01 (n = 610
SNPs), representing 441 different genes, PPI relationships were
examined with STRING v. 11.0 (see Figure 2). Restricted to
curated interaction scores with high confidence levels (≥ 0.7),
34 PPI clusters were generated, ranging in size from 2 to
22 nodes, comprising a total of 211 edges, with 264 of the
input genes isolated from the network (i.e., unconnected).
Given the number of genes examined, the expected number
of edges is 172, which yielded a PPI enrichment p-value of
2.31 × 10−3, thus suggesting broad patterns of biomolecular
connectivity among the gene products impacted by these
variants. Enrichment analyses were performed on the PPI
network (including unconnected nodes), with the following top-
enriched GO-terms (FDR = 0.0062): GO:0062023 “Collagen-
containing extracellular matrix” (13 of 144 genes belonging to
the GO-term category were counted); GO:0005929 “Cilium”
(31/570 count); and GO:0005604 “Basement membrane” (11/91
count). Reactome pathways were also tested, but none achieved
statistical significance. Narrowing the enrichment analysis to
the largest connected cluster in the network, color-coded in
Figure 2 as red (n = 22 nodes), the top-enriched GO-term
and Reactome pathway are GO:0062023 “Collagen-containing
extracellular matrix” (9/144 count; FDR = 4.48 × 10−12) and
HSA-1474244 “Extracellular matrix organization” (9/298 count;
FDR = 2.01× 10−9), respectively.
GSEA was also performed on the entire set of protein-
altering SNPs, with each of the impacted genes (n = 8,802
with human homologs) pre-ranked based on the intragenic SNP
with the best association result (and thus not relying on an
arbitrarily set p-value threshold that partitions the association
results). Three gene sets from the Reactome pathways and
GO-terms (Table 3) were found to exhibit significant positive
enrichment (i.e., overrepresentation among highly ranked genes).
Similar to the PPI network, enriched gene sets relate to collagen
and the extracellular matrix (ECM). The enriched Reactome
pathway is HSA-1474290 “Collagen formation” (FDR = 0.017;
see Figure 3A), with 63 genes in the pathway observed in the
pre-ranked list, with the top-ranked gene being ADAMTS3 (73rd
gene; max enrichment score (ES) at 2,832nd gene). For the GO-
terms, significant enrichment was detected for a pair of gene sets
related to the ECM, with the top result belonging to GO:0005201
“Extracellular matrix structural constituent” (FDR = 0.0072; see
Figure 3B), with 110 genes in the pre-ranked list, with the top-
ranked gene being MXRA5 (146th gene; max ES at 2,955th gene).
DISCUSSION
In this study, genetic association testing was performed for
epileptic seizure in a pedigreed baboon colony using available
WGS data from the NCBI SRA database. Targeting homologs of
genes previously implicated in human epilepsy, we observed a
significant association for an intronic SNP in the gene RBFOX1,
encoding an RNA-binding protein that regulates splicing,
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FIGURE 2 | PPI network for protein-altering SNPs with association p-values less than 0.01 for epileptic seizure. The overall network includes 34 clusters, ranging in
size from 2 to 22 nodes. The largest cluster is highlighted in red, with the top-enriched reactome pathway and GO-term listed. The analyses were conducted for 441
genes with human homolog counterparts with the online program STRING v. 11.0.
including transcripts of other epilepsy candidate genes (e.g.,
GABRG2, KCNQ2, SCN8A, SLC12A5, and SYN1, among others),
and plays a key role in neuronal excitation in the mammalian
brain (Gehman et al., 2011). A more agnostic approach was also
used in our analyses, as protein-altering SNPs were identified
throughout the baboon genome and tested for association
with epilepsy status. Although no significant associations were
observed, genes involved in the collagen-containing ECM
showed significant overrepresentation among top results. To
the best of our knowledge, these findings represent the first
TABLE 3 | Gene set enrichment analyses (GSEA) of association results for
protein-damaging SNPs.
Gene set Size NES FDR q-value
Reactome pathways
Collagen formation 63 2.62 1.67 × 10−2
GO-terms
ECM structural constituent 110 2.71 7.16 × 10−3
ECM structural constituent
conferring tensile strength
32 2.48 2.88 × 10−2
The table lists significant GSEA results for Reactome pathways and GO-terms
(MSigDB v. 7.2).
The gene list input is based on the association results for epileptic seizure in
baboons for 36,169 protein-damaging SNPs, pre-ranked according to the top
associations in each gene (negative logarithmic transformation of unadjusted
p-values).
Size is the number of pathway/GO-term genes observed in the gene list.
NES is the normalized enrichment score, which represents the degree to which a
gene set is overrepresented at the top (or bottom) of the pre-ranked list of genes.
characterization of potential variants underlying the genetic
architecture of epilepsy in baboons, pointing to commonalities
with what is known about the human genetic etiology, thus
suggesting the suitability of baboons as an animal model
for the disorder.
The RBFOX1 gene has repeatedly been linked to epilepsy, with
the earliest reports based on de novo structural gene variants
observed in patients comorbid for autism, (Martin et al., 2007)
intellectual disability, (Bhalla et al., 2004) or pontocerebellar
hypoplasia (Gallant et al., 2011). These findings were followed up
by a series of association studies by Lal et al. that targeted exon-
disrupting microdeletions in RBFOX1, revealing a significant
excess among GGE patients compared to population controls,
(Lal et al., 2013b) as well as among cases of Rolandic epilepsy
(Lal et al., 2013a) and sporadic focal epilepsy, (Lal et al.,
2015) suggesting that RBFOX1 deletions are involved in a wide
spectrum of both focal and generalized epilepsies. In mice, brain-
specific Rbfox1 knockouts have displayed spontaneous seizures
and heightened epileptogenic response to kainic acid (Gehman
et al., 2011). Although the pathophysiological mechanisms of
RBFOX1 remain to be clarified, more recent in vivo and
in vitro studies have yielded insights, including regulation of
cerebral cortex development, (Hamada et al., 2015) changes
to transcriptomic expression and splicing patterns of neuronal
genes, (Fogel et al., 2012) and crosstalk with microRNA miR-129-
5p that impacts homeostatic downscaling of excitatory synapses
(Rajman et al., 2017).
As one of the longest genes in the human genome, RBFOX1
has an extended 5′ region that harbors several transcription
start sites at varying first exons, enabling complex isoform
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FIGURE 3 | Top-enriched reactome pathway (A) and GO-term (B) for genes pre-ranked by their top SNP association p-value for epileptic seizure among
protein-altering variants. The analyses were performed on a total of 8,802 genes with human homologs with the program GSEA v. 4.1. Computation of the running
enrichment score was unweighted, with “hits” representing the pre-ranked genes belonging to the curated gene set.
versatility to produce differential patterns of subcellular and
tissue-specific localization (Conboy, 2017). The key regulatory
feature of the RBFOX1 protein, however, is located in the
downstream coding region, a single RNA recognition motif
(RRM) that preferentially binds the sequence (U)GCAUG in
pre-mRNA introns, mRNA 3′ UTRs, and microRNA hairpins.
Alternative splicing modulates the inclusion of the various exons
in this region, generating active and inactive forms of RRM,
as well as directing isoform localization. Overall, the gene is
highly conserved in most primates, including its homolog in
P.h. anubis that is approximately 92.4% identical to its human
counterpart, with a Gene Order Conservation score of 100
(Ensembl Release 102 data).
For the significant RBFOX1 association reported here, the
SNP is positioned in intron 3 (of 19 in total), which is part
of the extended 5′ region described above. In the human
genome (GRCh38), the SNP and its flanking 50 bp region aligns
within RBFOX1 at chromosome 16: 5,767,827–5,767,900 bp
(cytogenetic band 16p13.3) via the UCSC BLAST-like alignment
tool (score = 58; span = 74 bp; identity = 89.2%), and appears
to have limited functional and clinical relevance, besides a
few nearby cis-regulatory elements (DNase-H3K4me3, proximal
enhancer-like signatures). The intron itself harbors SNPs listed in
the NHGRI-EBI GWAS catalog (p < 1.0 × 10−5), with perhaps
the most noteworthy being rs13332522, a variant significantly
associated with ADHD-related variation in intracranial volume
(Klein et al., 2019). For GWAS of epilepsy, the recent mega-
analysis by ILAE is the most substantive dataset to-date, (The
International League Against Epilepsy Consortium on Complex
Epilepsies, 2018) revealing 16 genome-wide significant loci.
Although this does not include RBFOX1, a suggestive multi-
variant association signal is evident in intron 7 for GGE, with a
peak at rs11639540 (p = 1.84× 10−6).
Further, our analysis of genome-wide protein-damaging
variants in baboon indicates a potential etiological role for
collagen-containing ECM, with links to epilepsy reported
in literature. ECM has long been known to regulate various
aspects of neural development, providing structural support
(e.g., basement membrane scaffolded by collagen fibrils), and
stimulating various pathways that drive progenitor proliferation,
neuronal differentiation and migration, and synaptogenesis
(Long and Huttner, 2019). During epileptogenesis, the
perineuronal net (PNN), a condensed ECM structure that
envelops fast-spiking interneurons and that is responsible
for synaptic plasticity and excitation-inhibition stabilization,
has shown evidence of degradation by endogenous proteases,
resulting in impaired GABAergic inhibition (Tewari et al., 2018).
Matrix metalloproteinase-9 (MMP-9) is one such PNN protease,
which has exhibited increased mRNA and protein levels after
seizure in both animal models and patients, including generalized
tonic–clonic events, (Cudna et al., 2017) with inhibitors viewed
as potential therapeutic drug targets (Broekaart et al., 2021).
These findings provide a compelling first glimpse into the
genetic underpinnings of epilepsy in baboons, targeting common,
less penetrant risk variants in the allele frequency spectrum.
A significant burden of rare, deleterious microdeletions at
recurrent hotspots among neurodevelopmental genes and subject
to negative selection has been reported in GGE patients,
including RBFOX1 as noted above, and thus, analyses of
genome-wide indels in the baboon sequence data, including
the delineation of haplotype structures at key loci, could be
highly informative. Moreover, the sample size of this preliminary
investigation is relatively small and could be boosted by
additional baboons from the pedigreed colony, providing the
requisite power to detect novel risk variants that are rarer and
of smaller effect size. With its extensive archived WGS data and
veterinary records, the SNPRC colony could provide a unique
resource for epilepsy research, namely, a primate model with a
shared genetic etiology, which can garner new insights and lead
to much-needed alternative approaches to therapeutic treatment.
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